Sedation during spinal anaesthesia : A comparison between Dexmedetomidine and midazolam infusion.

Kshitija Bhagavan Savant, Harsha Patel, Vimal Patel


Objective: To study the effects of intravenous dexmedetomidine infusion and compare it with intravenous midazolam infusion during spinal anaesthesia (S/A) with regards to effect on psychomotor performance, memory and any side effect. Materials Methods: A prospective randomized double blind study was conducted on 60 patients of ASA I to III, scheduled for lower abdominal or lower limb surgery under S/A. All patients were randomly divided into two groups of 30 each; randomization was done by computer generated random numbers. In Group D, dexmedetomidine 1 ?g/kg and In Group M, midazolam 0.04 mg/kg basal infusion for 10 min then S/A was given with hyperbaric bupivacaine (0.5%). After achieving required level of S/A; position given and then infusion of inj. Dexmedetomidine 0.5g/kg/hr in group D and Inj. Midazolam 0.04mg/kg/hr by infusion started. Both psychomotor and memory test were performed before study drug infusion and after 1 and 4 hour of stoppage of infusion.

Results: Thus, in both the groups, psychomotor performance was not significantly changed as compared to baseline at 1 hour and 4 hour after stoppage of infusion. There was significantly decreased in recall of picture, after 1 hour of study drug infusion in both the groups (anterograde amnesia); which was regained at 1 hour after stoppage of infusion. The mean time required to achieved sedation score (RSS) of 3 were statistically significant shorter in group D as compared to in group M (P < 0.05). At the end of surgery, after stoppage of infusion of study drug, patients of group D achieved RSS score of 2 and that of group M which was comparable (p > 0.05).

Conclusion: Thus, we conclude that, Dexmedetomidine provide rapid onset of arousable sedation without causing respiratory and cardiovascular depression. It provides anterograde amnesia with rapid recovery of psychomotor function.


Spinal anaesthesia, dexmetomidine, midazolam

Full Text:



Copyright (c) 2017 International Journal of Biomedical and Advance Research

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.